Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb;174(2):W25-W29.
doi: 10.7326/L20-1446. Epub 2021 Jan 5.

Update Alert 7: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults

Katherine Mackey  1 , Devan Kansagara  1 , Kathryn Vela  1
Affiliations

Update Alert 7: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults

Katherine Mackey et al. Ann Intern Med. 2021 Feb.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Disclosures: Authors have disclosed no conflicts of interest. Forms can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=L20-1446.

Update of

References

    1. Mackey K , King VJ , Gurley S , et al. Risks and impact of angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers on SARS-CoV-2 infection in adults. A living systematic review. Ann Intern Med. 2020;173:195-203. doi: 10.7326/M20-1515 - DOI - PMC - PubMed
    1. Cheng X , Cai G , Wen X , et al. Clinical characteristics and fatal outcomes of hypertension in patients with severe COVID-19. Aging (Albany NY). 2020;12. [PMID: ] doi: 10.18632/aging.104019 - DOI - PMC - PubMed
    1. COVID-19 RISk and Treatments (CORIST) Collaboration.. RAAS inhibitors are not associated with mortality in COVID-19 patients: findings from an observational multicenter study in Italy and a meta-analysis of 19 studies. Vascul Pharmacol. 2020;135:106805. [PMID: ] doi: 10.1016/j.vph.2020.106805 - DOI - PMC - PubMed
    1. Genet B , Vidal JS , Cohen A , et al. COVID-19 in-hospital mortality and use of renin-angiotensin system blockers in geriatrics patients. J Am Med Dir Assoc. 2020;21:1539-1545. [PMID: ] doi: 10.1016/j.jamda.2020.09.004 - DOI - PMC - PubMed
    1. Kalra A , Hawkins ES , Nowacki AS , et al. Angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers: a comparison of outcomes in patients with COVID-19 [Letter]. Circ Cardiovasc Qual Outcomes. 2020;13:e007115. [PMID: ] doi: 10.1161/CIRCOUTCOMES.120.007115 - DOI - PMC - PubMed